TABLE 2.
Study | Country | Duration (weeks) |
Sample N/F/M |
Mean age (SD) | Exercise category |
Summary description of exercise intervention Frequency, intensity, time and type (F.I.T.T.) |
Outcome measures reported |
---|---|---|---|---|---|---|---|
Alizadeh et al. 38 | Iran | 12 |
15/15/0 15/15/0 15/15/0 |
34.5 (6.2) 33.1 (7.7) 32.4 (9.5) |
CON AE‐M AE‐M |
No exercise Continuous walking; 40 min; 65–75% HRmax; 5 days week−1 Intermittent walking; 3 bouts summing up to 40 min; 65–75% HRmax; 5 days week−1 |
Weight, BMI |
Alves et al. 39 | Brazil | 26 |
78/78/0 78/78/0 |
37 (10.6) 39.4 (11.1) |
CON AE‐M |
No exercise Continuous walking; 40 min; 40–60% HRR; 3 days week−1 |
Weight, BMI |
Arad et al. 40 | USA | 12 |
14/14/0 14/14/0 |
30.2 (7) 29.1 (4) |
CON AE‐V |
No exercise HITT: 6 min; 50% HRR, 4 intervals (60 s at 80–90% HRR) and 4 recovery minutes (210 s 50% HRR); 24 min; 3 days week−1 |
Weight, BMI, %fat, fitness |
Arslan 41 | Turkey | 8 |
20/20/0 29/29/0 |
37 (9.1) 41.6 (6.7) |
CON AE‐V |
No exercise Weeks 1–4: 60–70% HRmax; 40 min; 3 days week−1 and then Weeks 5–8: 80% HRmax; 50 min; 3 days week−1 (step‐aerobics) |
Weight, BMI, %fat |
Bonfante et al. 42 | Brazil | 26 |
10/0/10 12/0/12 |
49.1 (6.2) 49.1 (5.5) |
CON COM‐LM |
No exercise 60‐min session; resistance (3 sets of 8–10 max reps) and endurance (walking/running) 60–65% VO2 peak; 3 days week−1 |
Weight, BMI, WC, %fat, fitness, HDL, TG, FBG |
Borg et al. 43 | Finland | 26 |
27/0/27 28/0/28 29/0/29 |
35–50 d |
CON AE‐M R‐LM |
No exercise 60–70% VO2max, 45 min; 3 days week−1 60–75% 1RM, 8 reps/3 sets/6 exercises, 45 min; 3 days week−1 |
Weight, WC |
Chih‐Hui et al. 44 | Taiwan | 12 |
12/3/9 12/4/8 12/3/9 12/4/8 |
20.8 (0.7) 21.8 (0.7) 20.9 (0.4) 20.7 (0.6) |
CON AE‐M AE‐M AE‐V |
No exercise 40–50% HRR; 60 min; 3 days week−1 60–70% HHR; 60 min; 3 days week−1 70–80% HHR; 60 min; 3 days week−1 |
Weight, BMI, WC |
Church et al. 45 | USA | 26 |
96/96/0 145/145/0 90/90/0 96/96/0 |
57.2 (5.9) 57.9 (6.5) 56.7 (6.4) 56.4 (6.3) |
CON AE‐M AE‐M AE‐M |
No exercise 73 min week−1; 50% VO2 peak treadmill/cycle ergometer 139 min week−1; 50% VO2 peak treadmill/cycle ergometer 192 min week−1; 50% VO2 peak treadmill/cycle ergometer |
Weight, WC, %fat, fitness, HDL, TG, FBG |
Croymans et al. 46 | USA | 12 |
8/8/0 28/28/0 |
22.0 (1.5) 21.5 (2.1) |
CON R‐HI |
No exercise 3 days week−1; 60 min; 8 global exercises; 2 sets (15 reps); progressing from 100% 15 rep max to 100% 6 rep max |
Weight, BMI, WC, %fat, BP |
Dengel et al. 47 | USA | 52 |
9/0/9 10/0/10 |
62.8 (2.5) 60.3 (2.4) |
CON AE‐V |
No exercise 60% HRR; 30 min; 3 days week−1 progress to 85% HRR; 40 min |
Weight, %fat, fitness, FBG |
Donges et al. 48 | Australia | 12 |
11/0/11 12/0/12 12/0/12 12/0/12 |
49.5 (2.6) 45.4 (1.7) 51.7 (2.1) 46.2 (1.4) |
CON AE‐V R‐HI COM‐HI |
No exercise 75–80% HRmax; 40–60 min; 3 days week−1; cycle ergometer 75–80% 1RM; 10 exercises; 3–4 sets; 10 reps; 3 days week−1 50% aerobic as above and 50% resistance as above; 3 days week−1 |
Weight, %fat, fitness |
Donnelly et al. 49 , a | USA | 42 |
15/15/0 31/31/0 32/32/0 |
21.8 (2.6) 22.6 (2.9) 22.6 (3.2) |
CON AE‐V AE‐V |
No exercise 70–80% HRmax; 48 min; 5 days week−1; treadmill 70–80% HRmax; 63 min; 5 days week−1; treadmill |
Weight, BMI, %fat, fitness |
Donnelly et al. 49 , a | USA | 42 |
11/0/11 22/0/22 30/0/30 |
23.3 (3.4) 23.5 (3.2) 23.3 (3.7) |
CON AE‐V AE‐V |
No exercise 70–80% HRmax; 31 min; 5 days week−1; treadmill 70–80% HRmax; 42 min; 5 days week−1; treadmill |
Weight, BMI, %fat, fitness |
Foster‐Schubert et al. 50 | USA | 52 |
87/87/0 117/117/0 |
57.4 (4.4) 58.1 (5) |
CON AE‐V |
No exercise 70–85% HRmax; 45 min; 5 days week−1; treadmill or bike |
Weight, BMI, WC, %fat, fitness |
Frank et al. 51 | USA | 52 |
86/86/0 87/87/0 |
60.6 (6.6) 60.7 (6.7) |
CON AE‐M |
No exercise 60–75% HRR; 45 min; 5 days week−1 |
BMI, %fat, TG, FBG |
Gram et al. 52 | Denmark | 26 |
18/9/9 35/19/16 39/21/18 38/20/18 |
35 35 33 36 |
CON AE‐M AE‐M AE‐V |
No exercise 320 kcal (f)/425 kcal (m); 5 days week−1, no intensity prescribed 320 kcal (f)/425 kcal (m); 5 days week−1; 50% VO2 peak 320 kcal (f)/425 kcal (m); 5 days week−1; 70% VO2 peak |
BMI, fitness, HDL, TG |
Herring et al. 53 | UK | 12 |
10/−/− 11/−/− 12/−/− |
24–68 d |
CON R‐LM AE‐M |
No exercise 60% 1RM; global exercises; 45–60 min; 3 days week−1 50–70% HRmax: 45–60 min; 3 days week−1 |
BMI, WC, fitness |
Hintze et al. 54 | Canada | 52 |
34/24/0 36/36/0 |
29 25 |
CON R‐HI |
No exercise 70–80% 1RM; global; 45 min; 3 days week−1 |
Weight, BMI |
Ho et al. 15 , b | Australia | 12 |
21/−/− 25/−/− 26/−/− 25/−/− |
52 (1.8) 55 (1.2) 52 (1.1) 53 (1.3) |
CON AE‐M R‐ML COM‐ML |
No exercise 60% HRR; 30 min; 5 days week−1; walking 75% 1RM; 5 global exercises × 4 sets, 12 reps 60% HRR; 15 min; 5 days week−1 and 75% 1RM; 5 global exercises × 2 sets, 12 reps |
Weight, BMI, WC, %fat, HDL, TG, FBG |
Ho et al. 14 , b | Australia | 12 |
21/−/− 25/−/− 26/−/− 25/−/− |
52 (1.8) 55 (1.2) 52 (1.1) 53 (1.3) |
CON AE‐M R‐ML COM‐ML |
No exercise 60% HRR; 30 min; 5 days week−1; walking 75% 1RM; 5 global exercises × 4 sets, 12 reps 60% HRR; 15 min; 5 days week−1 and 75% 1RM; 5 global exercises × 2 sets, 12 reps |
BP |
Irving et al. 55 | USA | 16 |
9/9/0 15/15/0 12/12/0 |
51 (9) 51 (9) 51 (9) |
CON AE‐M AE‐V |
No exercise RPE 10–12; expenditure 400 kcal; 5 days week−1 RPE 15–17; expenditure 400 kcal; 5 days week−1 |
Weight, BMI, WC, %fat, fitness, BP, HDL, TG, FBG |
Irwin et al. 56 | USA | 52 |
86/86/0 85/85/0 |
60.5 (6.7) 60.6 (6.6) |
CON AE‐M |
No exercise 60–75% HRR; 45 min; 5 days week−1 |
Weight, BMI, %fat |
Jabbour 57 , c | Canada | 8 |
12/7/5 12/7/5 |
23.1 (3.3) 22.5 (2.3) |
CON AE‐V |
No exercise ~350% of VO2max × 6 s, followed by 2‐min recovery × 6 times; total duration = 15 min; 3 days week−1; cycle ergometer |
Weight, BMI, fitness |
Jabbour et al. 58 , c | Canada | 8 |
12/7/5 12/7/5 |
23.1 (3.3) 23.3 (3.3) |
CON AE‐V |
No exercise ~350% of VO2max × 6 s, followed by 2‐min recovery × 6 times; total duration = 15 min; 3 days week−1; cycle ergometer |
Weight, BMI |
Keating et al. 59 | Australia | 8 |
12/9/3 12/6/6 12/7/5 12/9/3 |
39.1 (2.9) 44.2 (2.8) 45.5 (2.3) 45.6 (3.6) |
CON AE‐V AE‐M AE‐M |
No exercise 70% VO2 peak; 45 min; 3 days week−1 50% VO2 peak; 60 min; 4 days week−1 50% VO2 peak; 45 min; 3 days week−1 |
Weight, BMI, WC, fitness, BP, HDL, TG, FBG |
Keating et al. 60 | Australia | 8 |
14/12/2 15/13/2 |
44.2 (2.8) 45.4 (1.9) |
CON R‐HI |
No exercise 80–85% 1RM; global exercises; 45–60 min; 3 days week−1 |
Weight, BMI, WC, fitness, BP, HDL, TG, FBG |
Kline et al. 61 | USA | 12 |
16/8/9 27/12/15 |
45.9 (2.2) 47.6 (1.3) |
CON COM‐LM |
No exercise 60% HHR × 40 min; 4 days week−1 and 8 global exercises; 2 sets × 12 reps; 2 days week−1 |
Weight, WC, %fat |
Mengistie et al. 62 | Ethiopia | 12 |
35/6/29 35/5/30 |
45.3 (5.4) 46.2 (5.5) |
CON COM‐LM |
No exercise 60–80% HRmax; 20 min; 4 days week−1; treadmill or bike and 70% 1RM; 7 exercise (2–3 sets, 12 reps); 20 min |
Weight, BMI, WC, %fat, fitness, BP, FBG |
Moghasdasi et al. 63 | Iran | 12 |
8/0/8 8/0/8 |
41.2 (6.1) 41.2 (6.1) |
CON AE‐V |
No exercise Treadmill; 75–80% VO2 peak; 45 min; 4 days week−1 |
Weight, BMI, %fat, fitness, FBG |
Mohanka et al. 64 | USA | 52 |
86/86/0 85/85/0 |
60.5 (6.7) 60.6 (6.6) |
CON AE‐M |
No exercise 60–75% HRR; 45 min; 5 days week−1 |
Weight, HDL, TG, fitness |
Mora‐Rodriguez et al. 65 | Spain | 26 |
20/−/− 20/−/− |
54 (9) 54 (9) |
CON AE‐V |
No exercise HITT (90% HRmax × 4 min, 70% HRmax × 3 min) × 45 min; 3 days week−1 |
Weight, BMI, WC, %fat, fitness, HDL, TG |
Nunes et al. 66 | Brazil | 16 |
13/13/0 13/13/0 12/12/0 |
54–65.5 d |
CON R‐ML R‐ML |
No exercise 70% 1RM; global; 3 sets/8–12 reps; 3 days week−1 × 16 weeks 70% 1RM; global; 6 sets/8–12 reps; 3 days week−1 × 16 weeks |
BMI, WC, %fat, HDL, TG |
Quist et al. 67 | Denmark | 26 |
18/9/9 35/19/16 39/20/19 38/20/18 |
35 (7) 35 (7) 33 (7) 27 (7) |
CON AE‐M AE‐M AE‐V |
No exercise Commuting to and from work; 45 min; 5 days 50% VO2max; 55 min; 5 days week−1; treadmill/cycle ergometer 70% VO2max; 37 min; 5 days week−1; treadmill/cycle ergometer |
Weight, BMI, fitness |
Ross et al. 68 | Canada | 26 |
70/49/26 73/49/24 76/49/27 76/49/27 |
52.2 (8.2) 52.1 (7.4) 50.9 (8.6) 50.3 (8.1) |
CON AE‐M AE‐M AE‐V |
No exercise 50% VO2 peak; 31 min; 5 days week−1; treadmill 50% VO2 peak; 58 min; 5 days week−1; treadmill 75% VO2 peak; 40 min; 5 days week−1; treadmill |
Weight, BMI, WC, %fat, fitness, BP, HDL, TG, FBG |
Rustaden et al. 69 | Norway | 12 |
36/36/0 37/37/0 35/35/0 35/35/0 |
40 (10) 30 (10) 38 (9) 42 (11) |
CON R‐HI R‐HI R‐HI |
No exercise Body pump; 800 reps between 10 exercises; 60 min; 3 days week−1 80–90% 1RM; 8 global exercises; 45 min; 3 days week−1 80–90% 1RM; 8 global exercises; 45 min; 3 days week−1 |
Weight, BMI, %fat |
Sarsan et al. 21 | Turkey | 12 |
24/24/0 26/26/0 26/26/0 |
43.6 (6.46) 41.7 (7.62) 42.5 (10.7) |
CON AE‐M R‐ML |
No exercise 50–80% HRR; 30–45 min; 5 days week−1; treadmill or bike 40–80% 1RM; 6 global exercises; 30–45 min; 3 days week−1 |
Weight, BMI, WC, fitness, BP |
Schroeder et al. 17 | USA | 8 |
17/11/6 17/10/7 17/10/7 18/11/7 |
58 (6) 58 (7) 57 (9) 58 (7) |
CON AE‐V R‐HI COM‐HI |
No exercise 85% HRmax; 60 min; 3 days week−1; treadmill or bike 12 global exercises; 3 sets 10–14 maximal repetitions 30 min of aerobic and 30‐min resistance programme |
Weight, BMI, WC, %fat, fitness, BP, HDL, TG, FBG |
Sheikholeslami‐Vatani et al. 70 | Iran | 8 |
10/0/10 10/0/10 10/0/10 |
23.2 (1.4) 23.2 (1.4) 23.2 (1.4) |
CON COM‐HI COM‐HI |
No exercise 80% HRmax; 10 min and 80% 1RM; 6 global exercises; 3 days week−1 80% HRmax; 10 min and 80% 1RM; 6 global exercises; 3 days week−1 |
Weight, BMI, %fat |
Soori et al. 71 | Iran | 8 |
8/8/0 8/8/0 8/8/0 8/8/0 |
45–60 d |
CON AE‐M R‐ML COM‐ML |
No exercise 40–75% HRmax; 45 min; 3 days week−1; swimming/water walking 40–60% 1RM; 6 global exercises × 3 sets (12 reps); 3 days week−1 22‐min aerobic (AE‐M); 22‐min resistance (R‐ML) programmes |
Weight, BMI, %fat, HDL, TG |
Stensvold et al. 13 | Norway | 12 |
11/−/− 11/−/− 11/−/− 10/−/− |
47.3 (10.2) 49.9 (10.1) 52.9 (10.4) 50.9 (7.6) |
CON AE‐V R‐HI COM‐HI |
No exercise 90–95% HRR; 4 min; 3‐min recovery; 4 times (45 min); 3 days week−1; treadmill 80% 1RM; 3 sets, 8–12 reps; 5 global exercises; 45 min; 3 days week−1 90–95% HRR; 4 min; 3‐min recovery; 4 times (45 min); 1 day week−1; treadmill and 80% 1RM; 3 sets, 8–12 reps; 5 global exercises; 45 min; 2 days week−1 |
Weight, BMI, WC, fitness, BP, HDL, TG, FBG |
Tjonne et al. 72 | Norway | 16 |
10/5/5 10/5/5 12/5/7 |
49.6 (9) 52 (10.6) 55.3 (13.2) |
CON AE‐M AE‐V |
No exercise 70% HRmax; 45 min; 3 days week−1; walking/running; treadmill 90% HRmax; 4 × 4‐min interval with 3 × 4‐min recovery |
Weight, BMI, WC, fitness, BP, HDL |
Tong et al. 73 | China | 12 |
18/18/0 18/18/0 18/18/0 |
21.3 (1) 21.3 (1) 20.7 (1.5) |
CON AE‐V AE‐V |
No exercise 80 × 6 s all‐out cycle sprint with 9 s passive recovery; 4 days week−1 90% VO2max × 4 min; 3‐min recovery (until 400 kJ achieved); 4 days week−1 |
Weight, BMI, %fat, fitness |
Tseng et al. 74 | Taiwan | 12 |
10/0/10 10/0/10 10/0/10 10/0/10 |
22 (0.7) 22.2 (1.1) 21.3 (0.6) 22.3 (1) |
CON AE‐M R‐ML COM‐ML |
No exercise 50–70% HRmax; 60 min; 5 days week−1 50–80% 1RM; 8 global exercises 3 sets × 12 reps; 5 days week−1 Aerobic (AE‐M) × 3 days and resistance (R‐ML) × 2 days |
Weight, BMI, WC, BP, TG, FBG |
Tumiati et al. 75 | Italy | 38 |
25/21/4 27/14/13 |
51 (11) 48 (12) |
CON COM‐LM |
No exercise 10% below maximal intensity reached in the 2kmWT; 50 min; 1 day week−1 and global resistance exercises; 2 days week−1 |
Weight, BMI, WC, fitness |
van Aggel‐Leijssen et al. 76 | Netherlands | 12 |
8/8/0 7/7/0 6/6/0 |
42.5 (6.4) 32.8 (9.6) 37.7 (6.4) |
CON AE‐M AE‐M |
No exercise 40% VO2max; 57 (6) min (250 kcal); 3 days week−1; cycle ergometer 40% VO2max; 57 (6) min (250 kcal); 3 days week−1; cycle ergometer |
Weight, BMI, %fat, fitness |
van Aggel‐Leijssen et al. 77 | Netherlands | 12 |
8/0/8 8/0/8 8/0/8 |
43.3 (5.4) 43.4 (6.3) 40 (6.3) |
CON AE‐M AE‐V |
No exercise 40% VO2max; 57 (8) min (350 kcal); 3 days week−1; cycle ergometer 70% VO2max; 33 (2) min (350 kcal); 3 days week−1; cycle ergometer |
Weight, BMI, %fat, fitness |
Note: –/–, gender not reported for specific groups.
Abbreviations: %fat, percentage body fat; 1RM, one repetition maximum; 2kmWT, 2‐km walk test; AE‐M, aerobic moderate intensity; AE‐V, aerobic vigorous intensity; BMI, body mass index; BP, blood pressure; COM‐HI, combination of high‐intensity aerobic and high‐load resistance exercise; COM‐LM, combination of low‐moderate intensity aerobic and low‐moderate load resistance exercise; CON, control group, no exercise; FBG, fasting blood glucose; FIT, fitness; HDL, high‐density lipoprotein; HITT, high‐intensity interval training; HRmax, heart rate maximum; HRR, heart rate reserve; R‐HI, resistance high load; R‐LM, resistance low‐moderate load; RPE, rate of perceived exertion; TG, triglycerides; VO2, oxygen uptake; WC, waist circumference.
Donnelly—same study but results for men and women reported separately.
Ho—same study but outcomes measures reported in two separate papers.
Jabbour—same study but outcome measures reported in two separate papers.
Age range for entire study sample not mean (SD).